Nutriventia Secures Strategic Growth Investment from NDude Labs

Indian nutraceutical ingredient supplier Nutriventia has closed a strategic growth investment from NDude Labs, a strategic investment firm.

“We built our proprietary delivery platforms to solve genuine pharmaceutical-grade challenges around bioavailability, stability, and dosing efficacy”, said Vishal Shah, co-founder and managing director of Nutriventia. “This partnership ensures that we can aggressively deepen our clinical pipeline and advance our delivery platforms without compromising on our scientific rigor.”, he added.

The investment will support Nutriventia’s clinical R&D and expand its portfolio of proprietary branded ingredients (TurmXTRA, CaffXtend, C-Fence, Melotime, Ashwanova (Prolanza), and ALAXTRA) while scaling the company’s proprietary E.D.G.E. low-dose delivery platform behind the next generation of actives.

Further, Nutriventia will build out a senior U.S. commercial team ahead of expansion into Europe and APAC, and broaden its scientific communication and thought leadership in key global markets.

“Every stage of Nutriventia’s growth has been anchored in one principle: lead with the science, and the market follows. NDude Labs recognized that our intellectual property is built on hard evidence rather than marketing narratives,” said Rajat Mittal Shah, co-founder and executive director, Nutriventia. “This investment allows us to accelerate our global commercial reach, and aggressively expand our commercial infrastructure across key international markets, establish direct leadership on the ground, and deliver our clinically validated branded ingredients to top-tier wellness brands worldwide.”, she further added.

Nitin Thakor, managing director at NDude Labs, said, “Nutriventia represents the kind of business we want to partner with at NDude Labs: science-led, innovation-driven and built in India with the potential to become a global category leader. We have been particularly impressed by the team’s ability to combine pharmaceutical-grade science with a deep understanding of what consumers and brands need, and to translate that into differentiated, clinically supported ingredients. We believe NDude’s operating experience, relationships across India and the U.S., and AI-native approach can help accelerate Nutriventia’s next phase of growth, and we are excited to work alongside Vishal and Rajat to build a category-leading business.”